Communities break fundraising record during The Longest Day
By
Foster Stubbs
Jul 24, 2024
63 Charter Senior Living communities across the nation raised money for Alzheimer’s research as part of the Alzheimer’s Association’s The Longest Day initiative. Find out more, and learn how to submit...
Dementia rate decline accelerates during COVID-19 pandemic
By
Eliza Mattson
Jul 23, 2024
Before the COVID-19 pandemic, the rate of older adults living with dementia was decreasing. The pandemic accelerated that decline, however, due to an increase in deaths among older adults living with dementia,...
Enacted bill shows that dementia resources are ‘high priority,’ industry advocate says
By
Lois A. Bowers
Jul 23, 2024
A long-term care provider advocate in South Carolina says that recently passed legislation “makes it clear that improving resources and access to care for those with Alzheimer’s disease is a high priority”...
Risk of Parkinson’s disease heightened in people with anxiety
Jul 22, 2024
Certain clinical features may identify those who may be in the prodromal phase of Parkinson’s disease.
State budget has ‘positive steps’ but does not do enough for providers, residents, groups say
By
Lois A. Bowers
Jul 22, 2024
Senior living industry advocates in Pennsylvania say they are encouraged by steps to support older adults evident in the recently passed state budget, but they say much more needs to be done to support...
Increasing RN staffing hours reduces injury-related ED visits by assisted living residents with dementia:...
By
Kimberly Bonvissuto
Jul 19, 2024
A new study found that increasing staffing hours of registered nurses in assisted living communities led to a 53% decrease in injury-related emergency department visits by residents living with Alzheimer’s...
Benzodiazepines not tied to higher dementia risk in older adults
Jul 16, 2024
Potential class-dependent associations may exist, however.
FDA clears nasal spray for moderate Alzheimer’s disease in first patient
By
Donna Shryer
Jul 16, 2024
Two recent developments in Alzheimer’s disease research offer new hope for patients and their families. Among these, in June, Tiziana Life Sciences received Food and Drug Administration clearance...
Metformin displayed a lowest risk for dementia across diverse antidiabetics, while α-glucosidase inhibitors had the highest risk.
More news for Monday, July 15
By
Kimberly Bonvissuto
Jul 15, 2024
CMS releases companion guide to Medicaid Access Rule … Racial disparities in dementia determined by social factors, not genetics … Addressing loneliness over time may play important role in stroke...